ACETO Appoints Edward J. Borkowski Chief Financial Officer
PORT WASHINGTON, N.Y., Feb. 16, 2018 - ACETO Corporation (Nasdaq:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced that it has appointed Edward J. Borkowski as Chief Financial Officer effective February 21, 2018.
“Ed brings the right combination of pharmaceutical financial management, business acumen and capital markets transactions and M&A experience that are integral to ACETO’s ongoing transition to a human health company and to our longer-term plans to balance our business model and enhance profitability through vertical integration and greater ownership of intellectual property,” said William C. Kennally, III, Chief Executive Officer of ACETO. “A seasoned and accomplished finance executive, Ed has a wealth of valuable experience growing companies organically and through strategic corporate development and he shares my passion for promoting a culture of accountability. On behalf of the entire ACETO team, I welcome Ed and look forward to his contributions to the company.”
Mr. Borkowski possesses nearly 20 years of executive financial and strategic leadership in healthcare and the specialty and generics pharmaceutical industry. Mr. Borkowski served as CFO at several healthcare companies including Concordia, where he was also a member of the board, Carefusion and Mylan. He began his career at Arthur Andersen. Mr. Borkowski has a B.S. in Economics and Political Science from Allegheny College and an MBA from Rutgers University.
About ACETO
ACETO Corporation, incorporated in 1947 and with offices and operations in 10 countries, is engaged in the development, marketing, sale and distribution of Human Health products (finished dosage form generics and nutraceuticals), Pharmaceutical Ingredients (pharmaceutical intermediates and active pharmaceutical ingredients) and Performance Chemicals (specialty chemicals and agricultural protection products).
